StockNews.com started coverage on shares of Check-Cap (NASDAQ:CHEK – Free Report) in a research note published on Monday. The brokerage issued a sell rating on the medical research company’s stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback